MJP
Michael J. Puzo Portfolio holdings
AUM
$351M
This Quarter Return
+9.69%
1 Year Return
+12.34%
3 Year Return
+65.3%
5 Year Return
+106.55%
10 Year Return
+254.06%
AUM
$265M
AUM Growth
+$265M
(+12%)
Cap. Flow
+$6.23M
Cap. Flow
% of AUM
2.35%
Top 10 Holdings %
Top 10 Hldgs %
38.05%
Holding
83
New
6
Increased
20
Reduced
37
Closed
–
Top Buys
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$6.08M |
| 2 |
PayPal
PYPL
|
$1.02M |
| 3 |
3M
MMM
|
$570K |
| 4 |
CELG
Celgene Corp
CELG
|
$522K |
| 5 |
Walt Disney
DIS
|
$507K |
Top Sells
| 1 |
Oracle
ORCL
|
$606K |
| 2 |
Mastercard
MA
|
$601K |
| 3 |
Automatic Data Processing
ADP
|
$566K |
| 4 |
Microsoft
MSFT
|
$475K |
| 5 |
Gilead Sciences
GILD
|
$433K |
Sector Composition
| 1 | Healthcare | 23.64% |
| 2 | Technology | 22.16% |
| 3 | Industrials | 14.49% |
| 4 | Financials | 12.07% |
| 5 | Consumer Staples | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Illumina
ILMN
$15.8B
| $3.78M | 1.43% |
10,303
+180
| +2% | +$66.1K |
|
27
EOG Resources
EOG
$68.2B
| $3.09M | 1.17% |
24,250
+252
| +1% | +$32.2K |
|
28
Chevron
CVX
$324B
| $3.06M | 1.16% |
25,057
+475
| +2% | +$58.1K |
|
29
Xylem
XYL
$34.5B
| $3.02M | 1.14% |
37,785
-125
| -0.3% | -$9.99K |
|
30
PepsiCo
PEP
$204B
| $2.55M | 0.96% |
22,787
| – | – |
|
31
Bank OZK
OZK
$5.91B
| $2.41M | 0.91% |
63,430
-3,000
| -5% | -$114K |
|
|
32
Oracle
ORCL
$635B
| $2.34M | 0.88% |
45,476
-11,750
| -21% | -$606K |
|
33
Merck
MRK
$210B
| $2.06M | 0.78% |
29,052
-850
| -3% | -$60.3K |
|
|
CELG
34
DELISTED
Celgene Corp
CELG
| $2.04M | 0.77% |
22,805
+5,832
| +34% | +$522K |
|
35
Fortive
FTV
$16.2B
| $1.7M | 0.64% |
20,233
| – | – |
|
36
AbbVie
ABBV
$372B
| $1.63M | 0.61% |
17,176
-500
| -3% | -$47.3K |
|
37
McCormick & Company Non-Voting
MKC
$18.9B
| $1.55M | 0.58% |
11,770
| – | – |
|
38
Emerson Electric
EMR
$74.3B
| $1.5M | 0.56% |
19,549
-265
| -1% | -$20.3K |
|
39
Visa
V
$683B
| $1.43M | 0.54% |
9,540
-200
| -2% | -$30K |
|
40
Empire State Realty Series ES
ESBA
$2.04B
| $1.31M | 0.49% |
78,323
-250
| -0.3% | -$4.17K |
|
|
41
Gilead Sciences
GILD
$140B
| $1.19M | 0.45% |
15,399
-5,599
| -27% | -$433K |
|
42
Schlumberger
SLB
$55B
| $1.12M | 0.42% |
18,424
+5,460
| +42% | +$333K |
|
|
RDS.A
43
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.1M | 0.41% |
16,100
| – | – |
|
|
44
PayPal
PYPL
$67.1B
| $1.02M | 0.38% |
+11,597
| New | +$1.02M |
|
|
45
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.02M | 0.38% |
4,750
-100
| -2% | -$21.4K |
|
46
Bristol-Myers Squibb
BMY
$96B
| $929K | 0.35% |
14,960
| – | – |
|
47
Union Pacific
UNP
$133B
| $905K | 0.34% |
5,558
| – | – |
|
48
Vanguard Total Stock Market ETF
VTI
$526B
| $898K | 0.34% |
6,000
-500
| -8% | -$74.8K |
|
49
J.M. Smucker
SJM
$11.8B
| $859K | 0.32% |
8,362
-3,875
| -32% | -$398K |
|
50
Pfizer
PFE
$141B
| $718K | 0.27% |
16,288
-100
| -0.6% | -$4.41K |
|